Piermont Valley Acquisition Corp. (CMCAF)

Piermont Valley Acquisition Corp is a blank check company, sometimes called a SPAC, formed to identify and acquire a business in consumer, consumer technology, financial services, healthcare, or media sectors. The company began trading publicly on December 1, 2021 under the symbol CMCA (Class A shares, units, and warrants), trading on the OTC market as CMCAF after a shift from primary exchange listing. It was originally incorporated as Capitalworks Emerging Markets Acquisition Corp and rebranded as Piermont Valley Acquisition Corp in February 2025. The company is based in Las Vegas, Nevada.

The blank check structure and purpose

A blank check company like Piermont Valley is essentially a shell — a publicly traded vehicle with minimal existing operations, assembled for the explicit purpose of merging with or acquiring an operating business. Shareholders who bought into the original public offering in 2021 made a bet on the sponsorship and expertise of the company’s founders and backers rather than on any concrete business already in place. The hope is that management will negotiate a merger at a reasonable valuation, one that existing shareholders can either stay for or exit before the deal closes.

The company collected capital through its initial public offering and held it in trust, bound by regulatory rules around how long the sponsors had to find and close a target (typically two years, extendable). Until a deal closed or the clock ran out, the cash sat in the trust account and the company operated on a shoestring, mainly searching for opportunities.

The Tigerless Health merger

In early 2026, Piermont Valley announced a definitive merger agreement with Tigerless Health Inc., an insurance technology startup founded in 2018 and headquartered in New York City. Tigerless Health focuses on making insurance simpler and more transparent for consumers — helping people understand, compare, and access coverage in categories including health, pet, and other insurance products. The transaction valued Tigerless Health at approximately 280 million dollars on an enterprise-value basis, meaning Piermont Valley was buying a relatively young company at a significant size.

The merger is expected to close during 2026, with the combined company planning to list on the Nasdaq under the name Tigerless Health Inc. The deal gives Tigerless a public listing and the capital and reporting infrastructure that comes with it, while Piermont Valley’s shareholders and sponsors gain exposure to an insurance technology business in a sector where consumers increasingly want digital-first experiences.

What to watch if you hold the stock

Until the merger closes, holders of Piermont Valley shares face two key decisions: whether to stay in the deal and move into Tigerless Health equity, or to exercise redemption rights before the vote (a feature of SPAC structures that lets shareholders withdraw their investment if they dislike the proposed merger). After closing, the company will stop being a shell and start being an operating insurance-technology business, at which point investors will evaluate Tigerless Health as they would any other public company — looking at customer growth, unit economics, cash burn, and the competitive landscape in insurance technology.

The insurance technology space has attracted substantial venture investment and several public competitors, so the real question for any investor is whether Tigerless Health’s product and market position can sustain growth and eventually profitability. That story begins after the merger closes.